Heterogeneity in drug disposition determines interindividual variability of docetaxel pharmacokinetics.
Figg
William D
WD
Molecular Pharmacology Section, Medical Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA. wdfigg@helix.nih.gov
Chau
Cindy H
CH
D000972:Antineoplastic Agents, Phytogenic / Q000493:pharmacokinetics*; D051544:Cytochrome P-450 CYP3A / Q000235:genetics* / Q000378:metabolism*; D000077143:Docetaxel; D006801:Humans; D043823:Taxoids / Q000493:pharmacokinetics*
D000972:Antineoplastic Agents, Phytogenic; D043823:Taxoids; D000077143:Docetaxel; D051544:Cytochrome P-450 CYP3A